Cargando…

Improving the metabolic fidelity of cancer models with a physiological cell culture medium

Currently available cell culture media may not reproduce the in vivo metabolic environment of tumors. To demonstrate this, we compared the effects of a new physiological medium, Plasmax, with commercial media. We prove that the disproportionate nutrient composition of commercial media imposes metabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vande Voorde, Johan, Ackermann, Tobias, Pfetzer, Nadja, Sumpton, David, Mackay, Gillian, Kalna, Gabriela, Nixon, Colin, Blyth, Karen, Gottlieb, Eyal, Tardito, Saverio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314821/
https://www.ncbi.nlm.nih.gov/pubmed/30613774
http://dx.doi.org/10.1126/sciadv.aau7314
_version_ 1783384166638813184
author Vande Voorde, Johan
Ackermann, Tobias
Pfetzer, Nadja
Sumpton, David
Mackay, Gillian
Kalna, Gabriela
Nixon, Colin
Blyth, Karen
Gottlieb, Eyal
Tardito, Saverio
author_facet Vande Voorde, Johan
Ackermann, Tobias
Pfetzer, Nadja
Sumpton, David
Mackay, Gillian
Kalna, Gabriela
Nixon, Colin
Blyth, Karen
Gottlieb, Eyal
Tardito, Saverio
author_sort Vande Voorde, Johan
collection PubMed
description Currently available cell culture media may not reproduce the in vivo metabolic environment of tumors. To demonstrate this, we compared the effects of a new physiological medium, Plasmax, with commercial media. We prove that the disproportionate nutrient composition of commercial media imposes metabolic artifacts on cancer cells. Their supraphysiological concentrations of pyruvate stabilize hypoxia-inducible factor 1α in normoxia, thereby inducing a pseudohypoxic transcriptional program. In addition, their arginine concentrations reverse the urea cycle reaction catalyzed by argininosuccinate lyase, an effect not observed in vivo, and prevented by Plasmax in vitro. The capacity of cancer cells to form colonies in commercial media was impaired by lipid peroxidation and ferroptosis and was rescued by selenium present in Plasmax. Last, an untargeted metabolic comparison revealed that breast cancer spheroids grown in Plasmax approximate the metabolic profile of mammary tumors better. In conclusion, a physiological medium improves the metabolic fidelity and biological relevance of in vitro cancer models.
format Online
Article
Text
id pubmed-6314821
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-63148212019-01-04 Improving the metabolic fidelity of cancer models with a physiological cell culture medium Vande Voorde, Johan Ackermann, Tobias Pfetzer, Nadja Sumpton, David Mackay, Gillian Kalna, Gabriela Nixon, Colin Blyth, Karen Gottlieb, Eyal Tardito, Saverio Sci Adv Research Articles Currently available cell culture media may not reproduce the in vivo metabolic environment of tumors. To demonstrate this, we compared the effects of a new physiological medium, Plasmax, with commercial media. We prove that the disproportionate nutrient composition of commercial media imposes metabolic artifacts on cancer cells. Their supraphysiological concentrations of pyruvate stabilize hypoxia-inducible factor 1α in normoxia, thereby inducing a pseudohypoxic transcriptional program. In addition, their arginine concentrations reverse the urea cycle reaction catalyzed by argininosuccinate lyase, an effect not observed in vivo, and prevented by Plasmax in vitro. The capacity of cancer cells to form colonies in commercial media was impaired by lipid peroxidation and ferroptosis and was rescued by selenium present in Plasmax. Last, an untargeted metabolic comparison revealed that breast cancer spheroids grown in Plasmax approximate the metabolic profile of mammary tumors better. In conclusion, a physiological medium improves the metabolic fidelity and biological relevance of in vitro cancer models. American Association for the Advancement of Science 2019-01-02 /pmc/articles/PMC6314821/ /pubmed/30613774 http://dx.doi.org/10.1126/sciadv.aau7314 Text en Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Vande Voorde, Johan
Ackermann, Tobias
Pfetzer, Nadja
Sumpton, David
Mackay, Gillian
Kalna, Gabriela
Nixon, Colin
Blyth, Karen
Gottlieb, Eyal
Tardito, Saverio
Improving the metabolic fidelity of cancer models with a physiological cell culture medium
title Improving the metabolic fidelity of cancer models with a physiological cell culture medium
title_full Improving the metabolic fidelity of cancer models with a physiological cell culture medium
title_fullStr Improving the metabolic fidelity of cancer models with a physiological cell culture medium
title_full_unstemmed Improving the metabolic fidelity of cancer models with a physiological cell culture medium
title_short Improving the metabolic fidelity of cancer models with a physiological cell culture medium
title_sort improving the metabolic fidelity of cancer models with a physiological cell culture medium
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314821/
https://www.ncbi.nlm.nih.gov/pubmed/30613774
http://dx.doi.org/10.1126/sciadv.aau7314
work_keys_str_mv AT vandevoordejohan improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium
AT ackermanntobias improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium
AT pfetzernadja improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium
AT sumptondavid improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium
AT mackaygillian improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium
AT kalnagabriela improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium
AT nixoncolin improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium
AT blythkaren improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium
AT gottliebeyal improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium
AT tarditosaverio improvingthemetabolicfidelityofcancermodelswithaphysiologicalcellculturemedium